A new study finds trends in colonoscopy rates did not fully align with the increase in colorectal cancer in younger adults, adding to evidence the rise in early onset CRC is not solely a result of more detection. The study is published online in the Journal of Medical Screening.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
